Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study.
Autor: | Ewenstein, B. M.1 bruce_ewenstein@baxter.com, Gomperts, E. D.1, Pearson, S.1, O'Banion, M. E.1 |
---|---|
Zdroj: | Haemophilia. Sep2004, Vol. 10 Issue 5, p491-498. 8p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |